Notice of a Meeting of a Working Group of the NIH Blue Ribbon Panel, 54640-54641 [2010-22323]
Download as PDF
<![CDATA[
jlentini on DSKJ8SOYB1PROD with NOTICES
54640
Federal Register / Vol. 75, No. 173 / Wednesday, September 8, 2010 / Notices
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Behrouz Shabestari, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
MSC 7854, Bethesda, MD 20892. (301) 435–
2409. shabestb@csr.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group,
Molecular Oncogenesis Study Section.
Date: October 14–15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Old Town Alexandria,
901 North Fairfax Street, Alexandria, VA
22314.
Contact Person: Nywana Sizemore, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6204,
MSC 7804, Bethesda, MD 20892. 301–435–
1718. sizemoren@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group, Nuclear and
Cytoplasmic Structure/Function and
Dynamics Study Section.
Date: October 14–15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The St. Regis Washington, DC, 923
16th and K Streets, NW., Washington, DC
20006.
Contact Person: David Balasundaram, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189,
MSC 7840, Bethesda, MD 20892. 301–435–
1022. balasundaramd@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group,
Pathogenic Eukaryotes Study Section.
Date: October 14–15, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Tera Bounds, DVM, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892. 301–435–
2306. boundst@csr.nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group, International and Cooperative
Projects—1 Study Section.
Date: October 14, 2010.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Nikko San Francisco, 222
Mason Street, San Francisco, CA 94102.
Contact Person: Dan D. Gerendasy, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5132,
MSC 7843, Bethesda, MD 20892. 301–594–
6830. gerendad@csr.nih.gov.
VerDate Mar<15>2010
16:41 Sep 07, 2010
Jkt 220001
Name of Committee: Immunology
Integrated Review Group, Immunity and Host
Defense Study Section.
Date: October 14–15, 2010.
Time: 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Old Town Alexandria, 1767
King Street, Alexandria, VA 22314.
Contact Person: Patrick K. Lai, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2215,
MSC 7812, Bethesda, MD 20892. 301–435–
1052. laip@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group,
Therapeutic Approaches to Genetic Diseases.
Date: October 14, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Avenue, NW., Washington, DC 20037.
Contact Person: Michael K. Schmidt, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2214,
MSC 7890, Bethesda, MD 20892. (301) 435–
1147. mschmidt@mail.nih.gov.
Name of Committee: Immunology
Integrated Review Group, Cellular and
Molecular Immunology—B Study Section.
Date: October 14–15, 2010.
Time: 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Magnificent Mile
Downtown Chicago, 165 E. Ontario Street,
Chicago, IL 60611.
Contact Person: Betty Hayden, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4206,
MSC 7812, Bethesda, MD 20892. 301–435–
1223. haydenb@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group, Genetic
Variation and Evolution Study Section.
Date: October 14–15, 2010.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The River Inn, 924 25th Street, NW.,
Washington, DC 20037.
Contact Person: David J. Remondini, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2210,
MSC 7890, Bethesda, MD 20892. 301–435–
1038. remondid@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: SAT and BTSS Study Sections.
Date: October 14, 2010.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: Roberto J. Matus, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
MSC 7854, Bethesda, MD 20892. (301) 435–
2204. matusr@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 1, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–22311 Filed 9–7–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of a Meeting of a Working
Group of the NIH Blue Ribbon Panel
The purpose of this notice is to inform
the public about a meeting of the NIH
Blue Ribbon Panel to Advise on the Risk
Assessment of the National Emerging
Infectious Diseases Laboratories at the
Boston University Medical Campus. The
meeting will be held Tuesday, October
5, 2010 at the Mainstage at Roxbury
Community College, 1234 Columbus
Avenue, Roxbury, MA from
approximately 6:30 p.m. to 10 p.m.
This public meeting is being held to
provide an update to the community on
the status and proposed approach of the
risk assessment for the BUMC NEIDL.
The meeting program will include an
update and review of the ongoing
supplementary risk assessment study as
well as opportunity for oral public
comment. In addition, at any time,
members of the public may file written
comments to the following address: NIH
Blue Ribbon Panel, Office of the
Director, National Institutes of Health,
Mail Stop Code 7985, Bethesda, MD
20892–7985 or by sending an e-mail to:
nih_brp@od.nih.gov.
An agenda and slides for the meeting
will be posted to the NIH Blue Ribbon
Panel Web site in advance of the
meeting at: https://nihblueribbonpanelbumc-neidl.od.nih.gov/. For additional
information concerning this meeting,
contact Ms. Kelly Fennington, Senior
Health Policy Analyst, Office of
Biotechnology Activities, Office of
Science Policy, Office of the Director,
National Institutes of Health, 6705
Rockledge Drive, Room 750, Bethesda,
MD 20892–7985; telephone 301–496–
9838; e-mail fennington@nih.gov.
E:\FR\FM\08SEN1.SGM
08SEN1
Federal Register / Vol. 75, No. 173 / Wednesday, September 8, 2010 / Notices
Dated: September 1, 2010.
Amy P. Patterson,
Acting Director, Office of Science Policy,
National Institutes of Health.
[FR Doc. 2010–22323 Filed 9–7–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Technologies to
Reduce Health Disparities SBIR 2011/01.
Date: November 3, 2010.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Ruixia Zhou, PhD,
Scientific Review Officer, 6707 Democracy
Boulevard, Democracy Two Building, Suite
957, Bethesda, MD 20892, 301–496–4773,
zhour@mail.nih.gov.
Dated: September 1, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–22329 Filed 9–7–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
jlentini on DSKJ8SOYB1PROD with NOTICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
VerDate Mar<15>2010
16:41 Sep 07, 2010
Jkt 220001
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
Date: November 9, 2010.
Time: 12:45 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy Two, 6707 Democracy Boulevard,
Bethesda, MD 20892.
Contact Person: Manana Sukhareva, PhD,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Suite 959, Bethesda,
MD 20892, 301–451–3397,
sukharem@mail.nih.gov.
Dated: September 1, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–22327 Filed 9–7–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Collaborative Applications in Adult
Psychopathology and Disorders of Aging.
Date: October 1, 2010.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
54641
Place: Hotel Palomar, 2121 P Street, NW.,
Washington, DC 20037.
Contact Person: Dana Jeffrey Plude, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3176,
MSC 7848, Bethesda, MD 20892, 301–435–
2309, pluded@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Cellular and Molecular
Biology of Glia Study Section.
Date: October 4–5, 2010.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 P Street, NW.,
Washington, DC 20037.
Contact Person: Toby Behar, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4136,
MSC 7850, Bethesda, MD 20892, (301) 435–
4433, behart@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neural Oxidative Metabolism
and Death Study Section.
Date: October 4–5, 2010.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Carol Hamelink, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192,
MSC 7850, Bethesda, MD 20892, (301) 213–
9887, hamelinc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Integrative Neuroscience.
Date: October 13–14, 2010.
Time: 7 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Brian Hoshaw, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181,
MSC 7844, Bethesda, MD 20892, 301–435–
1033, hoshawb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neural Control.
Date: October 13–14, 2010.
Time: 7 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Bernard F Driscoll, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, (301) 435–
1242, driscolb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Virology.
E:\FR\FM\08SEN1.SGM
08SEN1
]]>Agencies
[Federal Register Volume 75, Number 173 (Wednesday, September 8, 2010)]
[Notices]
[Pages 54640-54641]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-22323]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of a Meeting of a Working Group of the NIH Blue Ribbon
Panel
The purpose of this notice is to inform the public about a meeting
of the NIH Blue Ribbon Panel to Advise on the Risk Assessment of the
National Emerging Infectious Diseases Laboratories at the Boston
University Medical Campus. The meeting will be held Tuesday, October 5,
2010 at the Mainstage at Roxbury Community College, 1234 Columbus
Avenue, Roxbury, MA from approximately 6:30 p.m. to 10 p.m.
This public meeting is being held to provide an update to the
community on the status and proposed approach of the risk assessment
for the BUMC NEIDL. The meeting program will include an update and
review of the ongoing supplementary risk assessment study as well as
opportunity for oral public comment. In addition, at any time, members
of the public may file written comments to the following address: NIH
Blue Ribbon Panel, Office of the Director, National Institutes of
Health, Mail Stop Code 7985, Bethesda, MD 20892-7985 or by sending an
e-mail to: nih_brp@od.nih.gov.
An agenda and slides for the meeting will be posted to the NIH Blue
Ribbon Panel Web site in advance of the meeting at: https://nihblueribbonpanel-bumc-neidl.od.nih.gov/. For additional information
concerning this meeting, contact Ms. Kelly Fennington, Senior Health
Policy Analyst, Office of Biotechnology Activities, Office of Science
Policy, Office of the Director, National Institutes of Health, 6705
Rockledge Drive, Room 750, Bethesda, MD 20892-7985; telephone 301-496-
9838; e-mail fennington@nih.gov.
[[Page 54641]]
Dated: September 1, 2010.
Amy P. Patterson,
Acting Director, Office of Science Policy, National Institutes of
Health.
[FR Doc. 2010-22323 Filed 9-7-10; 8:45 am]
BILLING CODE 4140-01-P
